NEWSROOM

Stox Media – Wall Street Nation

SS Innovations Achieves Significant Milestones in 2023

SS Innovations Achieves Significant Milestones in 2023

Jan 8, 2024

Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures Company Builds Strong Foundation for Future Growth FORT LAUDERDALE, FL, January 8, 2024 - SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population,...

HOLIDAY ISLAND HOLDINGS, INC. IS CHANGING ITS NAME AND SYMBOL COMMENSURATE WITH ITS NEW PURSUITS INTO THE OIL & GAS INDUSTRY, AND ITS MANAGEMENT HAS BEEN ENHANCED

HOLIDAY ISLAND HOLDINGS, INC. IS CHANGING ITS NAME AND SYMBOL COMMENSURATE WITH ITS NEW PURSUITS INTO THE OIL & GAS INDUSTRY, AND ITS MANAGEMENT HAS BEEN ENHANCED

Jan 8, 2024

Holiday Island, Ark., Jan. 08, 2024 -- Holiday Island Holdings, Inc. (OTC: HIHI) – operating in the Secondary Recovery of Oil & Gas Industry – released the news today that it is changing its name to EP3 (Enhanced Petroleum Extraction Enterprises, Inc.) commensurate with its new pursuits in the Oil and Gas industry. As recently announced, Glenn Klinker has been added to our executive staff as the Company’s Chief Operating Officer responsible for the Oil & Gas operations. We have...

PRISM MarketView Launches Emerging Women’s Health Index

Jan 4, 2024

Global women’s health market projected to reach $67.07 billion by 2031 Private equity investment in women’s health exceeded $3 billion in 2022 New York, N.Y., January 4, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging Women’s Health Index. The growth of the women’s health market is accelerating with the introduction of next-generation therapeutics and artificial intelligence (AI) powered imaging and...

HOLIDAY ISLAND HOLDINGS, INC. IS CHANGING ITS NAME AND SYMBOL COMMENSURATE WITH ITS NEW PURSUITS INTO THE OIL & GAS INDUSTRY, AND ITS MANAGEMENT HAS BEEN ENHANCED

Holiday Island Holdings, Inc. is Cancelling the Merger With XA Interactive, Inc. and it Will Emerge With New Industry Experienced Executives, New Oil & Gas Business Plan, and a Significant Income Producing Asset

Jan 3, 2024

Holiday Island, Ark., Jan. 03, 2024 -- Holiday Island Holdings, Inc. (OTC: HIHI) (the "Company") – operating in the Secondary Recovery of Oil & Gas Industry – released the news today that it is cancelling the merger with XA Interactive, Inc., and it will emerge with new industry experienced executives, aggressively pursuing Oil and Gas opportunities, and a significant income producing asset. The Merger is being cancelled as numerous significant omissions were discovered in the Company's...

Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For December 2023

Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For December 2023

Jan 3, 2024

LOS ANGELES, January 03, 2024 - Clubhouse Media Group, Inc. (OTC: CMGR) ("CMGR"), a social media firm, today announced that HoneyDrip.com has seen month-over-month growth, continuing into December 2023. Honeydrip.com is a digital platform designed and wholly owned by CMGR with a focus on the empowerment of creators. The site allows creators to connect and engage with fans and monetize exclusive content. HoneyDrip.com has experienced rapid growth in four main categories during...

Sono-Tek Completes Senior Management Transition

Sono-Tek Completes Senior Management Transition

Jan 2, 2024

Dr. Christopher Coccio becomes Executive Chairman, Stephen Harshbarger appointed CEO MILTON, NY, January 02, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has completed the senior management transition that was previously announced at the Company’s most recent annual meeting on August 24, 2023. Effective as of December 31, 2023, Dr. Christopher L. Coccio transitioned from his position as Chief Executive...

Mass Megawatts Announces Expansion of LOWEST PRICE GUARANTEE Product Lines in 2024 with the 2023 Year End Tax Loss Selling Pressure of its Equity in the Rear View Mirror

Mass Megawatts Announces Expansion of LOWEST PRICE GUARANTEE Product Lines in 2024 with the 2023 Year End Tax Loss Selling Pressure of its Equity in the Rear View Mirror

Jan 2, 2024

WORCESTER, MA, January 02, 2024 – Mass Megawatts (OTC: MMMW) announces plans to introduce new products during 2024 including an off the grid solar application in January with a lowest price guarantee for solar projects that are substantially similar being quoted by other solar companies. At the same time, the new year brings relief of tax loss selling with its equity investors occurring at the end of the year 2023 especially in November and December. With the temporary pressure gone...

Boston Solar Named First US Partner for Energizer Solar, Pioneering Renewable Energy Solutions in the American Market

Boston Solar Named First US Partner for Energizer Solar, Pioneering Renewable Energy Solutions in the American Market

Jan 2, 2024

Boston, MA, January 2nd, 2024 – In a groundbreaking move that marks a significant milestone in the renewable energy sector, Boston Solar, a subsidiary of SinglePoint Inc. (CBOE: SING), a leader in solar energy solutions, has joined forces with Energizer Solar to launch Energizer Solar renewable energy solutions starting with the Energizer Solar home battery solution. Energizer Solar is a global powerhouse in energy products. Already highly successful in Australia, Germany and the UK, this...

PRISM MediaWire – Weekly Press Resume – Dec. 25 to Dec. 29, 2023

PRISM MediaWire – Weekly Press Resume – Dec. 25 to Dec. 29, 2023

Dec 29, 2023

New York, December 29, 2023 PRISM MediaWire - Weekly Press Resume Dec. 25 to Dec. 29, 2023 SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa https://prismmediawire.com/ss-innovations-announces-strategic-partnership-with-surgical-lab-for-distribution-in-africa/ SPZI: $53.4 million fully executed commodity contract closed https://prismmediawire.com/spzi-53-4-million-fully-executed-commodity-contract-closed/ Rodedawg Intl. Ind, Inc. (OTC: RWGI) Acquires...

Most Popular PRISM MarketView Articles in 2023

Most Popular PRISM MarketView Articles in 2023

Dec 29, 2023

New York, December 29, 2023 - 2023 was a year filled with significant developments in emerging stocks, featuring a wide range of topics from clinical updates and strategic partnerships to earnings reports. Notable stories include Oncocyte’s initiation of the FDA submission process for its kidney transplant monitoring test, SKYX’s partnership with Kichler, and Soluna’s robust Q3 earnings. The year also saw engaging discussions on unique topics like full moon trading, Thanksgiving strategies,...

Microbot Medical is Set to Progress its Liberty Robotic System into Pivotal Clinical Trial; Shares soar 60%

Microbot Medical is Set to Progress its Liberty Robotic System into Pivotal Clinical Trial; Shares soar 60%

Dec 28, 2023

New York, December 28, 2023 - Microbot Medical Inc. (Nasdaq: MBOT) has completed its GLP pivotal pre-clinical study for the LIBERTY® Endovascular Robotic Surgical System. The study, adhering to FDA guidelines and using a porcine model, successfully met all its objectives, including conducting 96 robotic navigations by three interventional radiologists. This involved evaluating target vessels and surrounding tissues with the LIBERTY system controlling various intravascular catheterization...

Enveric Biosciences Announces EB-003 as Lead Drug Candidate for Mental Health Disorders; Stock Jumps 37%

Enveric Biosciences Announces EB-003 as Lead Drug Candidate for Mental Health Disorders; Stock Jumps 37%

Dec 28, 2023

New York, December 28, 2023 - Enveric Biosciences (NASDAQ: ENVB), a biotechnology company specializing in developing novel treatments for mental health disorders, has named EB-003 as the lead candidate from its EVM301 Series. This series targets depression, anxiety, and addiction disorders. The selection of EB-003 is a key milestone for Enveric, transitioning the company from a discovery phase to a drug development phase. EB-003 is chosen for its potential to...

SinglePoint Successfully Lists on Cboe; Welcomes Tony Thomas as New Board Member in Expansion of Board Bolstering Company’s Commitment to Strategic Growth in the Solar Sector

SinglePoint Successfully Lists on Cboe; Welcomes Tony Thomas as New Board Member in Expansion of Board Bolstering Company’s Commitment to Strategic Growth in the Solar Sector

Dec 28, 2023

Phoenix, AZ, December 28, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint'' or “the Company'') a provider in renewable energy, energy supply and healthy building solutions is delighted to announce the appointment of Tony Thomas to its Board of Directors. Mr. Thomas brings a wealth of experience and expertise in strategic advisory, investment, and board governance. Mr. Thomas serves as a Managing Director and Head of the financial advisory and asset management practice of Harbor...

PRISM Emerging MedDevices Mover Spotlight: Milestone Scientific Inc. (MLSS)

PRISM Emerging MedDevices Mover Spotlight: Milestone Scientific Inc. (MLSS)

Dec 27, 2023

New York, December 27, 2023 - Milestone Scientific Inc. (NYSE:MLSS) has established itself in the field of biomedical technology with its focus on advanced injection technologies for medical and dental applications. The company holds over 19 US patents and 133 foreign patents. Its dental product, the Single Tooth Anesthesia System (STA), has received FDA and CE marketing clearance in more than 50 countries. The STA system utilizes computer-assisted technology for precise and consistent...

Immutep Advances Towards Phase III Trial for Lung Cancer Treatment with Positive Regulatory Feedback

Immutep Advances Towards Phase III Trial for Lung Cancer Treatment with Positive Regulatory Feedback

Dec 27, 2023

New York, December 27, 2023 - Immutep Limited (ASX: IMM; NASDAQ: IMMP), a trailblazing clinical-stage biotechnology company, has announced encouraging news from the Paul-Ehrlich-Institut (PEI), part of the Committee for Medicinal Products for Human Use (CHMP). This announcement marks a significant step forward in the company’s development of novel LAG-3 immunotherapies for cancer and autoimmune diseases. https://prismmarketview.com/companies/immutep-limited/#news Marc Voigt, CEO of Immutep...

SS Innovations Achieves Significant Milestones in 2023

SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa

Dec 26, 2023

Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surgical Lab has Begun Registration of SSi Mantra in 27 African countries FORT LAUDERDALE, FL, December 26, 2023 - SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population,...

PRISM MediaWire – Weekly Press Resume – Dec. 25 to Dec. 29, 2023

PRISM MediaWire – Weekly Press Resume – Dec. 18 to Dec. 22, 2023

Dec 22, 2023

New York, December 22, 2023 PRISM MediaWire - Weekly Press Resume Dec. 18 to Dec. 22, 2023 SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange https://prismmediawire.com/singlepoint-rings-the-opening-bell-at-cboe-global-markets-exchange/ MindMed Advances Treatment for Generalized Anxiety Disorder https://prismmediawire.com/mindmed-advances-treatment-for-generalized-anxiety-disorder/ PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?...

HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment

HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment

Dec 22, 2023

New York, December 22, 2023 - Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK), common stock for approximately $21.25 million, at a price of $1.4167 per share. Under the agreement, HOOKIPA is responsible for advancing its HIV program through the completion of a Phase 1b clinical trial. The company’s shares rose 52.65% on Thursday and 80.51% premarket on Friday. https://prismmarketview.com/companies/hookipa-pharma-inc/...

PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40%

PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40%

Dec 22, 2023

New York, December 22, 2023 - PetVivo Holdings, Inc. (Nasdaq: PETV) has achieved a distribution milestone, reporting a total of 4500 syringes of Spryng™ with OsteoCushion™ technology distributed to veterinarians in the 2023 calendar year. https://prismmarketview.com/companies/petvivo-holdings-inc/ Spryng, the company’s signature product, helps to manage lameness, joint pain and osteoarthritis in horses and small animals. Earlier this month, the company announced the sale of Spryng to more...

PRISM Analysis: Why Did CareCloud Shares Jump This Week?

PRISM Analysis: Why Did CareCloud Shares Jump This Week?

Dec 22, 2023

New York, December 22, 2023 - Healthcare technology solutions provider, CareCloud, Inc. (Nasdaq: CCLD) has seen a jump in its share price this week. The new momentum is being driven by the company’s financial and operational update, issued on Wednesday, and outlining an attractive roadmap for future growth. Shareholders rewarded CareCloud with a 25.61% increase following Wednesday’s session, and a 22.94% boost on Thursday. https://prismmarketview.com/companies/carecloud-inc/ Remarking on the...

Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start

Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start

Dec 21, 2023

New York, December 21, 2023 - In two weeks, 2023 will be history so consider this your reminder to start figuring out a resolution that likely will be forgotten, by this time next year. New Years is celebrated in a multitude of ways based on geography, culture, or religion. However, unlike other holidays, it is one that is observed by mostly everyone around the world. As always, PRISM has you covered as we close out the year and provide you with some “go-to” resolution ideas, highlight some...

Palatin Technologies Sells Vyleesi in $171M Transaction

Palatin Technologies Sells Vyleesi in $171M Transaction

Dec 21, 2023

New York, December 21, 2023 - Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to Cosette Pharmaceuticals, a US-based, specialty pharmaceutical company, for up to $171 million. Vyleesi is the first and only as-needed FDA-approved treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). https://prismmarketview.com/companies/palatin-technologies-inc/ Carl Spana, Ph.D., President and Chief Executive Officer of...

SinglePoint Successfully Lists on Cboe; Welcomes Tony Thomas as New Board Member in Expansion of Board Bolstering Company’s Commitment to Strategic Growth in the Solar Sector

SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange

Dec 21, 2023

Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30 million Completed $4,000,000 Underwritten Offering Capital Raise Phoenix, AZ, December 21, 2023 - SinglePoint Inc. (Cboe: SING) a leading renewable solar energy and sustainable solutions provider releases shareholder letter overviewing 2023 and Successful listing on Cboe BZX Exchange. Dear Shareholders, As we approach the end of a tough yet remarkable year, I am pleased to share a comprehensive...

Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial

Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial

Dec 21, 2023

New York, December 21, 2023 - Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct a phase 1/2 clinical trial using the company’s innovative StemSpine® treatment known as AlloStem™ (CELZ-201-DDT). https://prismmarketview.com/companies/creative-medical-technology-holdings-inc/ Timothy Warbington, CEO of Creative Medical Technology, said, “The FDA’s clearance and IRB approval allowing us to pursue this clinical trial is another...

PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%

PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%

Dec 20, 2023

New York, December 20, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights Panbela Therapeutics, Inc. which has announced that US WorldMeds®1 (USWM) has received FDA approval of its New Drug Application (NDA) for the use of eflornithine as a maintenance therapy for high-risk neuroblastoma patients. In July 2023, Panbela divested its pediatric neuroblastoma program to USWM in an arrangement entitling Panbela to up to approximately $9.5...

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

Dec 20, 2023

New York, December 20, 2023 - Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of strategic accomplishments on its first anniversary as a public company. Lipella is advancing three clinical indications and has been granted two Orphan Drug Designations by the US Food and Drug Administration (FDA). https://prismmarketview.com/companies/lipella-pharmaceuticals-inc/ Today, the company announced it has successfully completed a Type C meeting with...

Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership

Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership

Dec 20, 2023

New York, December 20, 2023 - Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more than 15% on Tuesday after the company announced it would expand its partnership with Walmart to offer a Buy Now, Pay Later (BNPL) service at self-checkout kiosks at over 4,500 Walmart stores in the United States. https://prismmarketview.com/companies/affirm-holdings-inc/ https://prismmarketview.com/buy-now-pay-later-affirm-shares-jump-on-news-of-walmart-partnership/ Pat Suh, Affirm’s...

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Dec 20, 2023

-Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company") a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity. Based in Pittsburgh, PA, the Company has made substantial strides over the past year, achieving critical milestones and advancing its pipeline with three clinical indications and two orphan drug designations...

SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

Dec 19, 2023

Phoenix, AZ, December 19, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better health and living, today announced the closing of its underwritten public offering of 800,000 shares of common stock at a public offering price of $5.00 per share. The gross proceeds from the offering, before underwriting discounts...

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

Dec 19, 2023

New York, December 19, 2023 - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary Tract infections (cUTI). The company’s shares surged 25% in trading on Monday following the news. https://prismmarketview.com/companies/nrx-pharmaceuticals-inc/ Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens have...